Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
about
An arched micro-injector (ARCMI) for innocuous subretinal injectionTransconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration.Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degenerationDisplacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumabSurgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13.Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm.Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.Clinical characteristics and current treatment of age-related macular degeneration.Intrasurgical assessment of subretinal tPA injection for submacular hemorrhage in the PIONEER study utilizing intraoperative OCT.Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator.Optical Coherence Tomographic Features and Prognosis of Pneumatic Displacement for Submacular Hemorrhage.Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive casesRetinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions.Surgical treatment of age-related macular degeneration.Treatment for submacular hemorrhage associated with neovascular age-related macular degeneration.Literature review of recombinant tissue plasminogen activator used for recent-onset submacular hemorrhage displacement in age-related macular degeneration.Radiating hemorrhage in exudative age-related macular degeneration.A New Method of Subretinal Injection of Tissue Plasminogen Activator and Air in Patients With Submacular Hemorrhage.Surgically Induced Focal Retinal Detachment Does Not Cause Detectable SD-OCT Retinal Changes in Normal Human RetinaSubretinal recombinant tissue plasminogen activator and pneumatic displacement for the management of subretinal hemorrhage occurring after anti-VEGF injections for wet AMD.Valsalva-Related Subretinal Hemorrhage as a Presenting Symptom of Polypoidal Choroidal Vasculopathy.Intravitreal recombinant tissue plasminogen activator without and with additional gas injection in patients with submacular haemorrhage associated with age-related macular degeneration.Massive subretinal and subretinal pigment epithelial hemorrhage displacement with perfluorocarbon liquid using a two-step vitrectomy technique.Compatibility of recombinant tissue plasminogen activator (rtPA) and aflibercept or ranibizumab coapplied for neovascular age-related macular degeneration with submacular haemorrhage.Polypoidal Choroidal Vasculopathy.
P2860
Q28541782-F21518D9-191A-4647-9779-4967A1E041F7Q33682143-923DFC36-B28F-48FC-BA39-14D4CCFA1C90Q33900503-2117D996-4661-472A-8085-8E96609CF8D1Q34019693-4C6E9F5A-39AE-4E82-BD54-9B859383E24DQ34081858-23468C50-4D19-43AC-AD94-724FB8C2D8B3Q34366841-0299867A-2D21-4AF1-BAF5-9F147349DE2FQ34565343-472CB520-1026-41B7-AE48-D755E2E988E5Q34930298-7B0C9635-7850-4B1E-9DD4-B9B6DDC3B489Q35598415-4AE8C6EF-A47A-4D8A-81E5-750D1243CE2FQ35761653-93798D51-37D2-4556-8DC4-0F5F8C0C5D23Q36228351-CB4C8C4E-86FB-4751-BD5D-CE7A4CF5B4D6Q37085388-32D65A78-2777-43D4-B38B-1704083DA86FQ37412847-7AB1C47E-299F-4BA4-90E0-B2DF56324519Q37879175-BCD13586-B892-4531-BF28-21EE564997F2Q37951624-ADBA718D-0137-4E0F-ADD9-AD10649D38E5Q38052994-9575A3F4-98BD-4008-A7BA-07A72A162D40Q40525714-2080BD99-ADC0-4068-8100-88341D4516B4Q41322369-3F5ABAFF-2287-4093-A414-52F07C770CB4Q42379453-3DD2BCAB-2B2A-4120-957D-213D5993938AQ42729433-85A61E40-4DFC-462C-A1CB-DEE9319523E0Q43375862-AFB35820-9622-45CE-92E3-179BE552772CQ44642952-EE62160E-D0B3-4578-AF2F-77E65609CF28Q52880725-61AAAB0E-B8F9-4000-8BAA-B2D2F9804E28Q54286581-BA567E92-AB7C-4A23-89A9-8B7E0580C8D4Q55714679-2C744506-2EF4-42EC-8C89-3ED34CD251CF
P2860
Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Subretinal recombinant tissue ...... -Related macular degeneration.
@en
Subretinal recombinant tissue ...... -Related macular degeneration.
@nl
type
label
Subretinal recombinant tissue ...... -Related macular degeneration.
@en
Subretinal recombinant tissue ...... -Related macular degeneration.
@nl
prefLabel
Subretinal recombinant tissue ...... -Related macular degeneration.
@en
Subretinal recombinant tissue ...... -Related macular degeneration.
@nl
P2093
P1433
P1476
Subretinal recombinant tissue ...... -Related macular degeneration.
@en
P2093
Carl C Awh
David R Chow
Kirk H Packo
Mathew W MacCumber
Sébastien Olivier
P304
P356
10.1016/J.OPHTHA.2003.10.020
P577
2004-06-01T00:00:00Z